Mirae Asset Global Etfs Holdings Ltd. Arrowhead Pharmaceuticals, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $47.1 Billion
- Q2 2025
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 151,275 shares of ARWR stock, worth $5.46 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
151,275
Previous 238,328
36.53%
Holding current value
$5.46 Million
Previous $3.04 Million
21.28%
% of portfolio
0.01%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding ARWR
# of Institutions
321Shares Held
99.1MCall Options Held
444KPut Options Held
568K-
Black Rock Inc. New York, NY15.7MShares$566 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.5MShares$561 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY10.6MShares$383 Million3.05% of portfolio
-
State Street Corp Boston, MA6.37MShares$230 Million0.0% of portfolio
-
Slate Path Capital LP New York, NY5.23MShares$189 Million1.65% of portfolio
About ARROWHEAD PHARMACEUTICALS, INC.
- Ticker ARWR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 105,849,000
- Market Cap $3.82B
- Description
- Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...